These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 27799660

  • 1. Toward Noninvasive Diagnosis of IgA Nephropathy: A Pilot Urinary Metabolomic and Proteomic Study.
    Neprasova M, Maixnerova D, Novak J, Reily C, Julian BA, Boron J, Novotny P, Suchanek M, Tesar V, Kacer P.
    Dis Markers; 2016; 2016():3650909. PubMed ID: 27799660
    [Abstract] [Full Text] [Related]

  • 2. The complex of immunoglobulin A and uromodulin as a diagnostic marker for immunoglobulin A nephropathy.
    Obara T, Mizoguchi S, Shimozuru Y, Sato T, Hotta O.
    Clin Exp Nephrol; 2012 Oct; 16(5):713-21. PubMed ID: 22415778
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic urinary proteome profile for immunoglobulin a nephropathy.
    Samavat S, Kalantari S, Nafar M, Rutishauser D, Rezaei-Tavirani M, Parvin M, Zubarev RA.
    Iran J Kidney Dis; 2015 May; 9(3):239-48. PubMed ID: 25957429
    [Abstract] [Full Text] [Related]

  • 4. Association of urinary laminin G-like 3 and free K light chains with disease activity and histological injury in IgA nephropathy.
    Rocchetti MT, Papale M, d'Apollo AM, Suriano IV, Di Palma AM, Vocino G, Montemurno E, Varraso L, Grandaliano G, Di Paolo S, Gesualdo L.
    Clin J Am Soc Nephrol; 2013 Jul; 8(7):1115-25. PubMed ID: 23599406
    [Abstract] [Full Text] [Related]

  • 5. Proteomic approach for identification of IgA nephropathy-related biomarkers in urine.
    Prikryl P, Vojtova L, Maixnerova D, Vokurka M, Neprasova M, Zima T, Tesar V.
    Physiol Res; 2017 Sep 22; 66(4):621-632. PubMed ID: 28406696
    [Abstract] [Full Text] [Related]

  • 6. Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases.
    Julian BA, Wittke S, Novak J, Good DM, Coon JJ, Kellmann M, Zürbig P, Schiffer E, Haubitz M, Moldoveanu Z, Calcatera SM, Wyatt RJ, Sýkora J, Sládková E, Hes O, Mischak H, McGuire BM.
    Electrophoresis; 2007 Dec 22; 28(23):4469-83. PubMed ID: 18004714
    [Abstract] [Full Text] [Related]

  • 7. IgA-containing immune complexes in the urine of IgA nephropathy patients.
    Matousovic K, Novak J, Yanagihara T, Tomana M, Moldoveanu Z, Kulhavy R, Julian BA, Konecny K, Mestecky J.
    Nephrol Dial Transplant; 2006 Sep 22; 21(9):2478-84. PubMed ID: 16757497
    [Abstract] [Full Text] [Related]

  • 8. Urinary proteome analysis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry with magnetic beads for identifying the pathologic presentation of clinical early IgA nephropathy.
    He Q, Shao L, Yu J, Ji S, Wang H, Mao Y, Chen J.
    J Biomed Nanotechnol; 2012 Feb 22; 8(1):133-9. PubMed ID: 22515101
    [Abstract] [Full Text] [Related]

  • 9. [Discriminant analysis of clinical markers before renal biopsy in patients with IgA nephropathy].
    Yagame M.
    Nihon Jinzo Gakkai Shi; 1989 Jul 22; 31(7):735-42. PubMed ID: 2585827
    [Abstract] [Full Text] [Related]

  • 10. Identification of a uromodulin fragment for diagnosis of IgA nephropathy.
    Wu J, Wang N, Wang J, Xie Y, Li Y, Liang T, Wang J, Yin Z, He K, Chen X.
    Rapid Commun Mass Spectrom; 2010 Jul 30; 24(14):1971-8. PubMed ID: 20552702
    [Abstract] [Full Text] [Related]

  • 11. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
    Berthelot L, Robert T, Vuiblet V, Tabary T, Braconnier A, Dramé M, Toupance O, Rieu P, Monteiro RC, Touré F.
    Kidney Int; 2015 Oct 30; 88(4):815-22. PubMed ID: 26061544
    [Abstract] [Full Text] [Related]

  • 12. Urinary prognostic biomarkers and classification of IgA nephropathy by high resolution mass spectrometry coupled with liquid chromatography.
    Kalantari S, Rutishauser D, Samavat S, Nafar M, Mahmudieh L, Rezaei-Tavirani M, Zubarev RA.
    PLoS One; 2013 Oct 30; 8(12):e80830. PubMed ID: 24339887
    [Abstract] [Full Text] [Related]

  • 13. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.
    Moldoveanu Z, Wyatt RJ, Lee JY, Tomana M, Julian BA, Mestecky J, Huang WQ, Anreddy SR, Hall S, Hastings MC, Lau KK, Cook WJ, Novak J.
    Kidney Int; 2007 Jun 30; 71(11):1148-54. PubMed ID: 17342176
    [Abstract] [Full Text] [Related]

  • 14. Comprehensive metabolomic profiling in early IgA nephropathy patients reveals urine glycine as a prognostic biomarker.
    Park S, Lee J, Yang SH, Lee H, Kim JY, Park M, Kim KH, Moon JJ, Cho S, Lee S, Kim Y, Lee H, Lee JP, Jeong CW, Kwak C, Joo KW, Lim CS, Kim YS, Hwang GS, Kim DK.
    J Cell Mol Med; 2021 Jun 30; 25(11):5177-5190. PubMed ID: 33939273
    [Abstract] [Full Text] [Related]

  • 15. [Establishment of enzyme-linked immunosorbent assay (ELISA) for measuring human urinary uromodulin and application of the method in patients with IgA nephropathy].
    Liu Y, Chen YQ, Zhou JJ, Han J, Liang Y, Li XY, Zhang H.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr 18; 44(2):307-10. PubMed ID: 22517010
    [Abstract] [Full Text] [Related]

  • 16. Complement components, proteolysis‑related, and cell communication‑related proteins detected in urine proteomics are associated with IgA nephropathy.
    Mucha K, Bakun M, Jaźwiec R, Dadlez M, Florczak M, Bajor M, Gala K, Pączek L.
    Pol Arch Med Wewn; 2014 Apr 18; 124(7-8):380-6. PubMed ID: 24938435
    [Abstract] [Full Text] [Related]

  • 17. [Expression and clinical implication of platelet-derived growth factor-D and platelet-derived growth factor-beta in childhood IgA nephropathy].
    Rong ZH, Wang C, Hao J, Duan HJ.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 May 18; 20(5):275-8. PubMed ID: 18471357
    [Abstract] [Full Text] [Related]

  • 18. Urine protein profile of IgA nephropathy patients may predict the response to ACE-inhibitor therapy.
    Rocchetti MT, Centra M, Papale M, Bortone G, Palermo C, Centonze D, Ranieri E, Di Paolo S, Gesualdo L.
    Proteomics; 2008 Jan 18; 8(1):206-16. PubMed ID: 18095357
    [Abstract] [Full Text] [Related]

  • 19. Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases.
    Julian BA, Wittke S, Haubitz M, Zürbig P, Schiffer E, McGuire BM, Wyatt RJ, Novak J.
    World J Urol; 2007 Oct 18; 25(5):467-76. PubMed ID: 17619884
    [Abstract] [Full Text] [Related]

  • 20. Uromodulin and α(1)-antitrypsin urinary peptide analysis to differentiate glomerular kidney diseases.
    Navarro-Muñoz M, Ibernon M, Bonet J, Pérez V, Pastor MC, Bayés B, Casado-Vela J, Navarro M, Ara J, Espinal A, Fluvià L, Serra A, López D, Romero R.
    Kidney Blood Press Res; 2012 Oct 18; 35(5):314-25. PubMed ID: 22399069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.